Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28626 - 28650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	PRSS35	167681	downregulated	Cytarabine results in decreased expression of PRSS35 mRNA	6q14.2	A21886
Cytarabine	Approved Investigational	PSD3	23362	upregulated	Cytarabine results in increased expression of PSD3 mRNA	8p22	A21886
Cytarabine	Approved Investigational	PSRC1	84722	downregulated	Cytarabine results in decreased expression of PSRC1 mRNA	1p13.3	A20666
Cytarabine	Approved Investigational	PSTPIP2	9050	downregulated	Cytarabine results in decreased expression of PSTPIP2 mRNA	18q21.1	A20985
Cytarabine	Approved Investigational	PTH1R	5745	downregulated	Cytarabine results in decreased expression of PTH1R mRNA	3p21.31	A21886
Cytarabine	Approved Investigational	PTPRZ1	5803	upregulated	Cytarabine results in increased expression of PTPRZ1 mRNA	7q31.32	A21886
Cytarabine	Approved Investigational	QPRT	23475	downregulated	Cytarabine results in decreased expression of QPRT mRNA	16p11.2	A21886
Cytarabine	Approved Investigational	RAB37	326624	downregulated	Cytarabine results in decreased expression of RAB37 mRNA	17q25.1	A21886
Cytarabine	Approved Investigational	RAB5B	5869	upregulated	Cytarabine results in increased expression of RAB5B mRNA	12q13	A20985
Cytarabine	Approved Investigational	RABGGTB	5876	downregulated	Cytarabine results in decreased expression of RABGGTB mRNA	1p31.1	A20985
Cytarabine	Approved Investigational	RAD23A	5886	downregulated	Cytarabine results in decreased expression of RAD23A mRNA	19p13.13	A20985
Cytarabine	Approved Investigational	RAD51	5888	upregulated	Cytarabine results in increased expression of RAD51 mRNA	15q15.1	A20985
Cytarabine	Approved Investigational	RAMP1	10267	downregulated	Cytarabine results in decreased expression of RAMP1 mRNA	2q37.3	A21886
Cytarabine	Approved Investigational	RASSF2	9770	upregulated	Cytarabine results in increased expression of RASSF2 mRNA	20p13	A21886
Cytarabine	Approved Investigational	RBM34	23029	downregulated	Cytarabine results in decreased expression of RBM34 mRNA	1q42.3	A20985
Cytarabine	Approved Investigational	RECQL5	9400	downregulated	Cytarabine results in decreased expression of RECQL5 mRNA	17q25	A20985
Cytarabine	Approved Investigational	RELN	5649	downregulated	Cytarabine results in decreased expression of RELN mRNA	7q22.1	A21886
Cytarabine	Approved Investigational	RERG	85004	downregulated	Cytarabine results in decreased expression of RERG mRNA	12p12.3	A21886
Cytarabine	Approved Investigational	REXO4	57109	downregulated	Cytarabine results in decreased expression of REXO4 mRNA	9q34.2	A21886
Cytarabine	Approved Investigational	RGL1	23179	downregulated	Cytarabine results in decreased expression of RGL1 mRNA	1q25.3	A21886
Cytarabine	Approved Investigational	RGMB	285704	upregulated	Cytarabine results in increased expression of RGMB mRNA	5q15	A21886
Cytarabine	Approved Investigational	RGS1	5996	downregulated	Cytarabine results in decreased expression of RGS1 mRNA	1q31.2	A21886
Cytarabine	Approved Investigational	RGS13	6003	downregulated	Cytarabine results in decreased expression of RGS13 mRNA	1q31.2	A21886
Cytarabine	Approved Investigational	RGS20	8601	upregulated	Cytarabine results in increased expression of RGS20 mRNA	8q11.23	A21886
Cytarabine	Approved Investigational	RGS4	5999	downregulated	Cytarabine results in decreased expression of RGS4 mRNA	1q23.3	A21886

Displaying entries 28626 - 28650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability